GUILFORD, Conn.–(BUSINESS WIRE)–Quantum-Si Incorporated (Nasdaq: QSI), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it will participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will participate in a virtual fireside chat on Thursday, November 18, 2021 at 2:30 p.m. ET.

A webcast of the event will be available on the Investors section of Quantum-Si’s website under Events & Presentations. A replay will be available on the Company’s website after the event.

About Quantum-Si

Founded by Dr. Jonathan Rothberg in 2013, Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.

Contacts

Investor Contacts
Juan Avendano

VP of Investor Relations

(413) 537-8735

javendano@quantum-si.com

Mike Cavanaugh

ICR Westwicke

(617) 877-9641

ir@quantum-si.com

Media Contact
Cammy Duong

ICR Westwicke

(203) 682-8380

QSI-PR@westwicke.com

close

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.